PMC3589122_01
(A) Preoperative fundus photograph. (B) Three months postoperative fundus photograph.
opth-7-427f7.jpg
PMC3589122_01_opth-7-427f7.jpg
f7-opth-7-427
Evaluation of the left eye showed a small cup-to-disc ratio, good rim coloration and perfusion, increasing vascular activity with radiation retinopathy, and a dome-shaped lesion with involution to a size of 9 x 8.5 x 1 mm, with focal exudative retinal detachment just superior to macula (Figure 7A). At 3 months follow-up, BCVA improved to 20/25, IOP was 13, and the primary tumor was stable, with laser ablation and intratumoral focal hemorrhage (Figure 7B).
Combined microincisional vitrectomy and phacoemulsification. (A) Phacomulsification with intraocular lens implantation. (B) 23-gauge pars plana vitrectomy, and membrane peel. (C) Laser tumor ablation.
opth-7-427f8.jpg
PMC3589122_01_opth-7-427f8.jpg
f8-opth-7-427
After the risks, benefits and alternatives were discussed, informed consent was obtained and the patient underwent 23G MIVS combined with phacoemulsification, IOL implantation, membrane peeling, endolaser tumor ablation, vitreous biopsy, and intravitreal triamcinolone acetonide injection to the left eye (Figure 8).